Literature DB >> 18425701

Ambulatory blood pressure variability is increased in diabetic hypertensives.

Motoko Ozawa1, Kouichi Tamura, Kousaku Iwatsubo, Kouhei Matsushita, Masashi Sakai, Yuko Tsurumi-Ikeya, Koichi Azuma, Atsuichiro Shigenaga, Yasuko Okano, Shinichiro Masuda, Hiromichi Wakui, Tomoaki Ishigami, Satoshi Umemura.   

Abstract

The purpose of this study was to examine the possible difference in the 24-hr BP profile--including short-term BP variability, assessed as the standard deviation--between diabetic and non-diabetic hypertensives. We measured 24-hr ambulatory BP in 11 diabetic hypertensives (diabetic HT) and 10 non-diabetic hypertensives (non-diabetic HT) who were hospitalized for the educational program in our hospital and were under stable salt intake. Renal function and sleep apnea were also estimated. There were no significant differences in 24-hr systolic BP (141 mmHg vs. 135 mmHg, ns), daytime systolic BP (143 mmHg vs. 138 mmHg, ns), and nighttime systolic BP (135 mmHg vs. 130 mmHg, ns) between diabetic HT and non-diabetic HT. The values of 24-hr HR (69.7 beats/min vs. 65.2 beats/min, ns) and 24-hr HR variability (9.9 beats/min vs. 10.1 beats/min, ns) were also similar between the groups. Interestingly, diabetic HT had a significantly greater 24-hr systolic and diastolic BP variability than non-diabetic HT (18.2 mmHg vs. 14.5 mmHg, p < 0.05; 11.5 mmHg vs. 9.6 mmHg, p < 0.05, respectively). The values for creatinine clearance, urinary protein excretion, and apnea-hypopnea index were similar between the groups. Bivariate linear regression analysis demonstrated that fasting blood glucose was the primary determinant of 24-hr diastolic BP variability (r = 0.661, p < 0.01). Multiple stepwise regression analysis revealed that fasting blood glucose was a significant and independent contributor to 24-hr systolic BP variability (r = 0.501, p < 0.05). Taken together, these results demonstrate that BP variability is increased in diabetic hypertensives. Furthermore, it is possible that an elevation of fasting blood glucose may contribute to the enhanced BP variability in hypertensives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425701     DOI: 10.1080/10641960802068477

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  14 in total

1.  Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure.

Authors:  Hisako Ushio; Tomoaki Ishigami; Naomi Araki; Shintaro Minegishi; Koichi Tamura; Yasuko Okano; Kazuaki Uchino; Osamu Tochikubo; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

2.  BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.

Authors:  David J Leehey; Jane H Zhang; Nicholas V Emanuele; Adam Whaley-Connell; Paul M Palevsky; Robert F Reilly; Peter Guarino; Linda F Fried
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-19       Impact factor: 8.237

Review 3.  Methods of Blood Pressure Measurement to Predict Hypertension-Related Cardiovascular Morbidity and Mortality.

Authors:  Thwe Htay; Damaris Rosado; Dale Quest; Jessica Giller; Najjar Haya; Sarah Ream; Jorge Cervantes
Journal:  Curr Cardiol Rep       Date:  2022-02-09       Impact factor: 2.931

Review 4.  Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Paolo Salvi; Carolina Lombardi; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 5.  Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

6.  Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study.

Authors:  Yook-Chin Chia; Kazuomi Kario; Naoko Tomitani; Sungha Park; Jinho Shin; Yuda Turana; Jam Chin Tay; Peera Buranakitjaroen; Chen-Huan Chen; Satoshi Hoshide; Jennifer Nailes; Huynh Van Minh; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Boon Wee Teo; Narsingh Verma; Yuqing Zhang; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

7.  Association of Serum Uric Acid Level With Blood Pressure Variability in Newly Diagnosed Essential Hypertension.

Authors:  Kumral Çağlı; Osman Turak; Uğur Canpolat; Fırat Özcan; Derya Tok; Mehmet Ali Mendi; Fatih Öksüz; Dimitrie Siriopol; Gabriel Veisa; Adrian Covic; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-07       Impact factor: 3.738

8.  Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011.

Authors:  Seung-Hyun Ko; Hyuk-Sang Kwon; Dae Jung Kim; Jae Hyeon Kim; Nan Hee Kim; Chul Sik Kim; Kee-Ho Song; Jong Chul Won; Soo Lim; Sung Hee Choi; Kyungdo Han; Yong-Moon Park; Bong-Yun Cha
Journal:  Diabetes Metab J       Date:  2014-02-19       Impact factor: 5.376

9.  Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes.

Authors:  Hiroyuki Iuchi; Masaya Sakamoto; Hirofumi Suzuki; Yosuke Kayama; Kennosuke Ohashi; Takeshi Hayashi; Sho Ishizawa; Tamotsu Yokota; Katsuyoshi Tojo; Michihiro Yoshimura; Kazunori Utsunomiya
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

10.  Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients.

Authors:  Daniela Massierer; Liana Farias Leiria; Mateus Dorneles Severo; Priscila Dos Santos Ledur; Alexandre Dalpiaz Becker; Fernanda Mus Aguiar; Eliandra Lima; Valéria Centeno Freitas; Beatriz D Schaan; Miguel Gus
Journal:  BMC Cardiovasc Disord       Date:  2016-01-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.